(Q21560815)

31 August 2022

Shona Kerr

7

Shona

Kerr

1 reference

31 August 2022

Mark Bronsvoort

10

Mark

Bronsvoort

1 reference

31 August 2022

David J Porteous

11

David J

Porteous

1 reference

31 August 2022

14

Andrew

Leigh-Brown

Andrew Leigh-Brown

1 reference

31 August 2022

Nigel J McLeish

1

Nigel J

McLeish

1 reference

31 August 2022

Chris Robertson

3

Chris

Robertson

1 reference

31 August 2022

Ian Handel

4

Ian

Handel

1 reference

31 August 2022

Mark McGilchrist

5

Mark

McGilchrist

1 reference

31 August 2022

Brajendra K Singh

6

Brajendra K

Singh

1 reference

31 August 2022

Margo E Chase-Topping

8

Margo E

Chase-Topping

1 reference

31 August 2022

Katy Sinka

9

Katy

Sinka

1 reference

31 August 2022

William Carman

12

William

Carman

1 reference

31 August 2022

James McMenamin

13

James

McMenamin

1 reference

31 August 2022

Mark E J Woolhouse

15

Mark E J

Woolhouse

1 reference

Creative Commons Attribution 4.0 International

31 August 2022

language of work or name

English

0 references

publication date

2011

0 references

published in

PLOS One

0 references

volume

6

0 references

issue

6

0 references

page(s)

e20358

0 references

copyright license

start time

8 June 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Managing and reducing uncertainty in an emerging influenza pandemic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110753

Generation Scotland: the Scottish Family Health Study; a new resource for researching genes and heritability

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110753

Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110753

Evaluation of serological diagnostic methods for the 2009 pandemic influenza A (H1N1) virus

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110753

Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110753

Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110753

Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110753

Serological response in RT-PCR confirmed H1N1-2009 influenza a by hemagglutination inhibition and virus neutralization assays: an observational study

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110753

High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110753

Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110753

Vaccine effectiveness in pandemic influenza - primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110753

2009 pandemic influenza A(H1N1) virus in Scotland: geographically variable immunity in Spring 2010, following the winter outbreak.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110753

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110753

"I-MOVE" towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110753

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110753

Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling

12 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020358

10.1371/JOURNAL.PONE.0020358

21 January 2018

Identifiers

DOI

0 references

ADS bibcode

2011PLoSO...620358M

0 references

Fatcat ID

release_r5nzkgpkljepfoz4bmz5t2lcte

0 references

PMC publication ID

3110753

0 references